Principal, EcoR1 Capital
Caroline Stout is a Principal at EcoR1 Capital, a biotechnology focused investment fund in San Francisco. She focuses on investments in private and public therapeutics companies, across indications and stages of development. She serves as a board member to Prevail Therapeutics and Accent Therapeutics. Prior to joining EcoR1 Capital, Caroline worked in New York as an investment banker at Credit Suisse. Caroline graduated magna cum laude from Georgetown University with a bachelor’s degree in Economics, a pre-medical concentration, and a minor in Cognitive Science.